| Stage | DUK | % of rev | GNE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.6B | 100.00% | $100M | 100.00% | DUK ×75.62 |
| Gross profit | $4.2B | 54.82% | $34M | 33.54% | DUK +21.3pp |
| Operating income | $2.0B | 26.99% | $7M | 6.50% | DUK +20.5pp |
| Pre-tax income | $1.3B | 17.19% | $12M | 11.63% | DUK +5.6pp |
| Net income | $1.1B | 15.08% | $11M | 11.39% | DUK +3.7pp |
| Stage | DUK | GNE | Gap · A − B |
|---|---|---|---|
| Revenue | $7.6B100.00% | $100M100.00% | DUK ×75.62 |
| Gross profit | 54.82%$4.2B | 33.54%$34M | DUK +21.3pp |
| Operating income | 26.99%$2.0B | 6.50%$7M | DUK +20.5pp |
| Pre-tax income | 17.19%$1.3B | 11.63%$12M | DUK +5.6pp |
| Net income |
| 15.08%$1.1B |
| 11.39%$11M |
| DUK +3.7pp |
No shared counterparties.